id: maud_underutilization_to_preventable_mortality_cirrhosis
name: Systemic MAUD Underutilization â†’ Preventable Mortality in Alcohol-Associated
  Cirrhosis
from_node:
  node_id: maud_underutilization
  node_name: Systemic MAUD Underutilization
to_node:
  node_id: preventable_mortality_cirrhosis
  node_name: Preventable Mortality in Alcohol-Associated Cirrhosis
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Only 9.7% of patients with alcohol-associated cirrhosis and high-risk alcohol
  use receive MAUD despite evidence of efficacy'
- 'Step 2: Structural barriers including lack of provider training, prescribing authority
  restrictions, and inadequate integration of addiction treatment into hepatology
  prevent wider adoption'
- 'Step 3: Patients continue hazardous alcohol use without evidence-based pharmacotherapy'
- 'Step 4: Continued alcohol consumption drives cirrhosis progression, decompensation,
  and mortality'
- 'Step 5: Population-level excess mortality occurs due to treatment gap'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: A. Rabiee et al. 2023. "Medications for alcohol use disorder improve
    survival in patients with hazardous drinking and alcohol-associated cirrhosis."
    *Hepatology Communications*. https://doi.org/10.1097/HC9.0000000000000093
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.337473'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: healthcare_system_type
  direction: strengthens
  strength: moderate
  description: Veterans Affairs system may have better MAUD access than fragmented
    private insurance markets, suggesting even lower utilization in other contexts
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/maud_underutilization_to_preventable_mortality_cirrhosis.yaml
_category: healthcare_access
